Investigations of the bioavailability of β-escin after oral administration of different formulations;Untersuchung der Bioverfugbarkeit von β-Aescin nach oraler Verabreichung verschiedener Darreichungsformen

Pharmazie

Volumn 51, Issue 8, 1996, Pages 608-610

  Dittgen, M ^a   Zimmermann, H ^a   Wober, W ^b   Hoflich C ^b   Breitbarth, H ^a   Timpe, C ^a  

^a BAYER PHARMA AG   (Germany)

^b Institute for Clinical Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AESCULUS HIPPOCASTANUM EXTRACT; BETA ESCIN; ESCIN;

ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RADIOIMMUNOASSAY; ADOLESCENT; ADULT; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG DOSAGE FORM; HALF LIFE TIME; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DOSAGE FORMS; ESCIN; HALF-LIFE; HUMANS; MALE; RADIOIMMUNOASSAY;

EID: 0030209752     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Kunz, K.; Schaffler, K.; Biber, A.; Wauschkuhn, C. H.: Pharmazie 46, 145 (1991)
2. Schrader, E.; Schwankl, W.; Sieder, C.; Christoffel, V.: Pharmazie 50, 623 (1995)
3. Gresske, K.: Pharm. Ztg. 139, 9 (1994)
4. Kolkmann, R.; Böttcher, F.: Pharm. Ztg. 139, 77 (1994)
5. Greeske, K.: Pharm. Ztg. 139, 78 (1994)
6. Hentschel, C.; Schössler, W.; Liebrich, G.; Brattström, A.: Pharmazie 49, 929 (1994)
7. EC Guideline III/54/89 "Investigation of Bioailability and Bioequivalence"
8. Monographie: Hippocastani semen (Roßkastaniensamen). BAnz. Nr. 71 v. 15.4. 1994